Abstract
Purpose of review: To review current knowledge of different cancer states affecting women with HIV infection. Recent findings: With improved survival of persons with HIV in the post-cART era, the landscape of malignancies in this population has greatly changed with fewer AIDS-defining malignancies (ADM) and a growing number of non-AIDS defining malignancies (NADM). Women, however, continue to represent a vulnerable population at risk for certain ADM and NADM such as cervical, anal, and breast cancer. Human papillomavirus-mediated cancers disproportionately burden women in resource-poor settings such as sub-Saharan Africa. For cancers such as Kaposi's sarcoma, lung cancer, liver cancer, and colorectal cancer, women share a lower burden of disease compared with their male counterparts. However, there remains a dearth of evidence characterizing these disease states specifically among women. Summary: Cancer in women with HIV continues to be a major source of morbidity and mortality worldwide, especially in low-income countries. Screening strategies, primary prevention through vaccination against human papillomavirus and viral hepatitis, and treatment for HIV with combined antiviral therapy remain cornerstones in cancer prevention.
Original language | English (US) |
---|---|
Pages (from-to) | 69-76 |
Number of pages | 8 |
Journal | Current Opinion in HIV and AIDS |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - 2017 |
Externally published | Yes |
Keywords
- Breast cancer
- Cancer
- Cervical cancer
- HIV
- Human papillomavirus
- Women
ASJC Scopus subject areas
- Immunology
- Hematology
- Oncology
- Oncology(nursing)
- Infectious Diseases
- Virology